Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recipients of Allogeneic Stem Cell Transplantation”

119 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 119 results

Not applicableEnded earlyNCT01077440
What this trial is testing

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Who this might be right for
Cancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more
Vanderbilt University 24
Not applicableStudy completedNCT04645667
What this trial is testing

Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant (HCT)

Who this might be right for
Acute GVHD
UNC Lineberger Comprehensive Cancer Center 38
Early research (Phase 1)Ended earlyNCT01643603
What this trial is testing

Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies

Who this might be right for
Non-Hodgkin's LymphomaHodgkin's LymphomaMyeloid Leukemia+3 more
Barbara Ann Karmanos Cancer Institute 5
Not applicableStudy completedNCT03448471
What this trial is testing

Severe Fatigue in Stem Cell Transplantation

Who this might be right for
Stem Cell TransplantationFatigue
Gazi University 49
Testing effectiveness (Phase 2)Study completedNCT01249820
What this trial is testing

Pharmacokinetics of Anidulafungin (Ecalta ®) Intravenous Given to Patients at High Risk for Developing Invasive Fungal Disease

Who this might be right for
LeukemiaMyelodysplastic SyndromeLeukemia, Myeloid, Acute
Radboud University Medical Center 26
Large-scale testing (Phase 3)Study completedNCT03930615
What this trial is testing

Extension of Letermovir (LET) From Day 100 to Day 200 Post-transplant for the Prevention of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant (HSCT) Participants (MK-8228-040)

Who this might be right for
Cytomegalovirus Infection
Merck Sharp & Dohme LLC 220
Not applicableStudy completedNCT01278927
What this trial is testing

Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)

Who this might be right for
Physiological Stress
Medical College of Wisconsin 711
Testing effectiveness (Phase 2)UnknownNCT05914714
What this trial is testing

Ruxolitinib as GVHD Prophylaxis in AA Patients

Who this might be right for
The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA
Institute of Hematology & Blood Diseases Hospital, China 46
Testing effectiveness (Phase 2)Ended earlyNCT03720392
What this trial is testing

Fecal Microbiota Transplantation (FMT) in Recipients After Allogeneic Hematopoietic Cell Transplantation (HCT)

Who this might be right for
Allogeneic Hematopoietic Cell Transplantation (HCT)
Zachariah Michael DeFilipp 8
Testing effectiveness (Phase 2)Study completedNCT01991067
What this trial is testing

Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients

Who this might be right for
Tick Borne Encephalitis
Medical University of Vienna 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT04692181
What this trial is testing

SYN-004 Safety and Tolerability in Allo-HCT Subjects

Who this might be right for
Acute Graft-Versus-Host Reaction Following Bone Marrow TransplantPrevention of CDI in Adult Patients Being Treated With IV Beta-lactam Antibiotics
Theriva Biologics, Inc. 36
Large-scale testing (Phase 3)Study completedNCT03565900
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Allogeneic Hematopoietic Stem Cell Transplant Recipients (V114-022/PNEU-STEM)

Who this might be right for
Pneumococcal Infections
Merck Sharp & Dohme LLC 277
Testing effectiveness (Phase 2)Active Not RecruitingNCT06019507
What this trial is testing

TCD601 in the Induction of Tolerance in de Novo Liver Transplantation

Who this might be right for
Liver Transplantation
ITB-Med LLC 12
Early research (Phase 1)Study completedNCT00673868
What this trial is testing

Cytomegalovirus (CMV) Specific Cytotoxic T Lymphocytes (CTL) When Used for Prophylaxis Against CMV in Recipients of Allogeneic, T Cell Depleted Stem Cell Transplants

Who this might be right for
Cytomegalovirus Infections
Milton S. Hershey Medical Center 2
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Testing effectiveness (Phase 2)WithdrawnNCT02346617
What this trial is testing

Adoptive Transfer of pp65-specific T Cells for the Treatment of Refractory Cytomegalovirus (CMV) Infection

Who this might be right for
Cytomegalovirus Infections
Yae-Jean Kim
Early research (Phase 1)WithdrawnNCT00002956
What this trial is testing

Immunotherapy for Lymphoproliferative Diseases Associated With Epstein-Barr Virus in Patients Who Have Undergone Organ Transplants

Who this might be right for
LeukemiaLymphoma
University of Alabama at Birmingham
Large-scale testing (Phase 3)Study completedNCT01877655
What this trial is testing

Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)

Who this might be right for
Cytomegalovirus (CMV)-Positive RecipientsAllogeneic, Hematopoietic Cell Transplant (HCT)
Astellas Pharma Global Development, Inc. 514
Early research (Phase 1)Study completedNCT01026987
What this trial is testing

Granulocyte Colony-stimulating Factor (G-CSF) Plus or Minus AMD3100 for Engraftment Post Allogeneic Transplant

Who this might be right for
Stem Cell Transplant Patients
Washington University School of Medicine 29
Testing effectiveness (Phase 2)Study completedNCT01573182
What this trial is testing

Herpes Zoster Vaccine for Bone Marrow Transplant Donors

Who this might be right for
Herpes Zoster
University of Sydney 8
Load More Results